Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced that Michel ...
1hon MSN
While I got ya, here are nine things and one crazy prediction: 1. Sad farewell to UT president Jay Hartzell Jay Hartzell may be leaving Austin as UT president after five years but not to worry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback